Pharma News

(Business Wire India; 12th May, 2014); New data has shown that treatment with melt-in-the-mouth desmopressin (MINIRIN® Melt)* improved sleep patterns and psychological functioning (including attention problems and memory) in children with nocturnal enuresis (bedwetting). The negative impact of bedwetting on children’s neuropsychological functioning (e.g. anxiety and social self-esteem problems) was also shown. The data from a study by researchers at the University Hospital Ghent, Belgium was presented at the 25th annual congress of the European Society for Paediatric Urology (ESPU) in Innsbruck, Austria.

(11th May, 2014); CSIR-Institute of Himalayan Bioresource Technology (CSIR-IHBT), Palampur, has developed unique autoclavable Super Oxide Dismutase (SOD) enzyme, used in cosmetic, food and pharmaceutical industries for end applications, like developing anti-ageing creams, extending shelf life of fruits and vegetables and during cryo-surgery and preservation of organelles, respectively.

(PRNewswire; 6th May, 2014); ACG's continued commitment towards sustainability and efforts in building sustainable sites, reducing water and energy consumption, recycling building material and improving indoor environmental quality has now been recognized. Indian Green Building Council (IGBC) LEED®-India has awarded its prestigious Gold rating to ACG's new state-of-the-art capsule manufacturing plant in Pithampur, making it the first factory in Indian pharmaceutical industry to receive this rating.

(6th May, 2014);As per new findings by investigators from King’s College London, Eczema caused by defects in the skin could reduce the risk of developing skin cancer. The immune response generated by eczema could help prevent tumour formation by shedding potentially cancerous cells from the skin.

(2nd May, 2014); Team of researchers from Montana State University showing that skin cells from infertile man can be used to create, primary germ cells - precursors of sperm. This research is providing ray of hope for future treatment of male infertility.

(1st May, 2014); At the AAN meeting in Philadelphia, two separate studies showed that electroCore’s non invasive vagus nerve stimulation (nVNS) therapy was effective in helping patients with different types of migraine. The first poster presentation, on April 28th, found that two hours after treatment with electroCore’s nVNS therapy patients who had both chronic migraine and medication overuse headache were pain free in 33% of attacks while significant pain relief (mild or no pain) was noted in 50% of attacks. In the second poster presented on May1st it was found that 45 % of patients, with migraine without aura, were pain free within 30 minutes of just one dose of nVNS therapy.

(28th Apr, 2014); In their last meeting, Drugs Technical Advisory Board (DTAB) raised the issue of wide variation in the quality of generic drugs manufactured in the country by small scale sector. The generic medicines of lower quality have not been found effective in patients.

(28th April, 2014); Strides Arcolab announced on 25th April that its Oral Dosage Forms  manufacturing site (KRS Gardens) in Bangalore was recently inspected by the USFDA as part of  GMP compliance audit and the facility continues to be approved.